190 related articles for article (PubMed ID: 11250879)
1. Pharmacological analysis of cannabinoid receptor activity in the rat vas deferens.
Christopoulos A; Coles P; Lay L; Lew MJ; Angus JA
Br J Pharmacol; 2001 Mar; 132(6):1281-91. PubMed ID: 11250879
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationship for the endogenous cannabinoid, anandamide, and certain of its analogues at vanilloid receptors in transfected cells and vas deferens.
Ross RA; Gibson TM; Brockie HC; Leslie M; Pashmi G; Craib SJ; Di Marzo V; Pertwee RG
Br J Pharmacol; 2001 Feb; 132(3):631-40. PubMed ID: 11159715
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological characterisation of cannabinoid CB(1) receptors in the rat and mouse.
Lay L; Angus JA; Wright CE
Eur J Pharmacol; 2000 Mar; 391(1-2):151-61. PubMed ID: 10720647
[TBL] [Abstract][Full Text] [Related]
4. Inhibition by cannabinoid receptor agonists of acetylcholine release from the guinea-pig myenteric plexus.
Coutts AA; Pertwee RG
Br J Pharmacol; 1997 Aug; 121(8):1557-66. PubMed ID: 9283688
[TBL] [Abstract][Full Text] [Related]
5. Effects of cannabinoid receptor agonists on neuronally-evoked contractions of urinary bladder tissues isolated from rat, mouse, pig, dog, monkey and human.
Martin RS; Luong LA; Welsh NJ; Eglen RM; Martin GR; MacLennan SJ
Br J Pharmacol; 2000 Apr; 129(8):1707-15. PubMed ID: 10780977
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effects of cannabinoid receptor ligands on electrically-evoked responses in rat isolated tracheal ring segments.
Yousif MH; Oriowo MA
Pharmacol Res; 1999 Nov; 40(5):415-21. PubMed ID: 10527656
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological characterization of three novel cannabinoid receptor agonists in the mouse isolated vas deferens.
Pertwee RG; Griffin G; Lainton JA; Huffman JW
Eur J Pharmacol; 1995 Sep; 284(3):241-7. PubMed ID: 8666005
[TBL] [Abstract][Full Text] [Related]
8. SR141716A, a potent and selective antagonist of the brain cannabinoid receptor.
Rinaldi-Carmona M; Barth F; Héaulme M; Shire D; Calandra B; Congy C; Martinez S; Maruani J; Néliat G; Caput D
FEBS Lett; 1994 Aug; 350(2-3):240-4. PubMed ID: 8070571
[TBL] [Abstract][Full Text] [Related]
9. Effects of cannabinoid receptor activation on rabbit bisected vas deferens strips.
Barun S; Vural IM; Dileköz E; Ercan ZS; Sarioglu Y
Clin Exp Pharmacol Physiol; 2005 Sep; 32(9):702-7. PubMed ID: 16173925
[TBL] [Abstract][Full Text] [Related]
10. The role of cannabinoid receptors in intestinal motility, defaecation and diarrhoea in rats.
Izzo AA; Mascolo N; Pinto L; Capasso R; Capasso F
Eur J Pharmacol; 1999 Nov; 384(1):37-42. PubMed ID: 10611417
[TBL] [Abstract][Full Text] [Related]
11. Characterization of cannabinoid modulation of sensory neurotransmission in the rat isolated mesenteric arterial bed.
Duncan M; Kendall DA; Ralevic V
J Pharmacol Exp Ther; 2004 Oct; 311(1):411-9. PubMed ID: 15205450
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effect of the cannabinoid receptor agonist WIN 55,212-2 on pentagastrin-induced gastric acid secretion in the anaesthetized rat.
Coruzzi G; Adami M; Coppelli G; Frati P; Soldani G
Naunyn Schmiedebergs Arch Pharmacol; 1999 Dec; 360(6):715-8. PubMed ID: 10619190
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of SR141716A on G-protein activation in rat brain.
Sim-Selley LJ; Brunk LK; Selley DE
Eur J Pharmacol; 2001 Mar; 414(2-3):135-43. PubMed ID: 11239913
[TBL] [Abstract][Full Text] [Related]
14. Further evidence for the presence of cannabinoid CB1 receptors in guinea-pig small intestine.
Pertwee RG; Fernando SR; Nash JE; Coutts AA
Br J Pharmacol; 1996 Aug; 118(8):2199-205. PubMed ID: 8864562
[TBL] [Abstract][Full Text] [Related]
15. Modulation of ATP-mediated contractions of the rat vas deferens through presynaptic cannabinoid receptors.
Tambaro S; Mongeau R; Dessi C; Pani L; Ruiu S
Eur J Pharmacol; 2005 Nov; 525(1-3):150-3. PubMed ID: 16271359
[TBL] [Abstract][Full Text] [Related]
16. Biochemical and pharmacological characterisation of SR141716A, the first potent and selective brain cannabinoid receptor antagonist.
Rinaldi-Carmona M; Barth F; Héaulme M; Alonso R; Shire D; Congy C; Soubrié P; Brelière JC; Le Fur G
Life Sci; 1995; 56(23-24):1941-7. PubMed ID: 7776817
[TBL] [Abstract][Full Text] [Related]
17. Activation of brain-type cannabinoid receptors interferes with preimplantation mouse embryo development.
Yang ZM; Paria BC; Dey SK
Biol Reprod; 1996 Oct; 55(4):756-61. PubMed ID: 8879486
[TBL] [Abstract][Full Text] [Related]
18. Further evidence for the presence of cannabinoid CB1 receptors in mouse vas deferens.
Pertwee RG; Joe-Adigwe G; Hawksworth GM
Eur J Pharmacol; 1996 Jan; 296(2):169-72. PubMed ID: 8838453
[TBL] [Abstract][Full Text] [Related]
19. Modulation of electrically evoked acetylcholine release through cannabinoid CB1 receptors: evidence for an endocannabinoid tone in the human neocortex.
Steffens M; Szabo B; Klar M; Rominger A; Zentner J; Feuerstein TJ
Neuroscience; 2003; 120(2):455-65. PubMed ID: 12890515
[TBL] [Abstract][Full Text] [Related]
20. Cannabinoid receptor activation in CA1 pyramidal cells in adult rat hippocampus.
Kirby MT; Hampson RE; Deadwyler SA
Brain Res; 2000 Apr; 863(1-2):120-31. PubMed ID: 10773200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]